THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Study: Sarbanes-Oxley costs burden small firms

By Chris Reidy
Globe Staff / March 1, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

A Greater Boston Chamber of Commerce study released yesterday says the new Sarbanes-Oxley law imposes expensive compliance burdens on small companies, such as biotech and life science firms that are crucial to the future of the Massachusetts economy. (Full article: 433 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly